Cargando…

QOL-18. A LONGITUDINAL STUDY OF NEUROCOGNITION IN CHILDREN TREATED FOR A BRAIN TUMOR

It is well known that neurocognition in children treated for a brain tumor can be affected. However, studies on the trajectory of these neurocognitive problems are scarce. In the present study we investigated the evolution of neurocognition between timepoints of diagnosis, 2, 4 and 6 years later. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemiere, Jurgen, Van den Wyngaert, Linde, Vandereydt, Josefien, Vandenabeele, Karen, Vercruysse, Trui, Sleurs, Charlotte, Jacobs, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Neuropsychology/Quality of Life
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715696/ http://dx.doi.org/10.1093/neuonc/noaa222.680

Ejemplares similares

QOL-19. PARENT-REPORTED COGNITIVE PROBLEMS AND DIRECT ASSESSMENT OF COGNITION IN CHILDREN TREATED FOR A BRAIN TUMOR
por: Lemiere, Jurgen, et al.
Publicado: (2020)

QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
por: Bullens, Kristien, et al.
Publicado: (2022)

QOL-08. Visual memory and potential clinical risk factors in long-term survivors of a childhood brain tumor
por: Sleurs, Charlotte, et al.
Publicado: (2022)

QOL-07. CORTICAL VOLUME AND THICKNESS IN ADULT SURVIVORS OF CHILDHOOD POSTERIOR FOSSA TUMORS
por: Sleurs, Charlotte, et al.
Publicado: (2020)

QOL-01. LONGITUDINAL COMPARISON OF NEUROCOGNITIVE TRAJECTORIES IN PEDIATRIC MEDULLOBLASTOMA PATIENTS TREATED WITH PROTON VERSUS PHOTON RADIOTHERAPY
por: Kahalley, Lisa, et al.
Publicado: (2020)

QOL-28. NEUROCOGNITIVE PROFILE OF PEDIATRIC MEDULLOBLASTOMA PATIENTS PRIOR TO RADIATION THERAPY
por: Baig, Muhammad, et al.
Publicado: (2020)

QOL-17. Neurocognitive outcomes after treatment for medulloblastoma with reduced primary site target volume margins
por: Larkin, Trisha, et al.
Publicado: (2022)

QOL-10. Treatment-induced leukoencephalopathy in pediatric medulloblastoma survivors and its impact on long-term neurocognitive functioning
por: Wägner, Lukas, et al.
Publicado: (2022)

QOL-04. INFLUENCE OF FAMILY, SCHOOL, AND HOSPITAL SYSTEMS IN SUPPORTING SURVIVORS OF PEDIATRIC BRAIN TUMORS WITH NEUROCOGNITIVE LATE EFFECTS
por: Moscato, Emily, et al.
Publicado: (2020)

QOL-11. COMPARISON OF TREATMENT BURDEN RATING SCALES ON NEUROCOGNITIVE OUTCOMES IN A MIXED SAMPLE OF PEDIATRIC BRAIN TUMOR SURVIVORS
por: Baig, Muhammad, et al.
Publicado: (2020)

QOL-53. GENOME ASSOCIATIONS WITH NEUROCOGNITIVE OUTCOMES, CEREBRAL MICROBLEEDS (CMBS), AND BRAIN VOLUME AND WHITE MATTER (WM) CHANGES IN PEDIATRIC BRAIN TUMOR SURVIVORS
por: Kline, Cassie, et al.
Publicado: (2020)

QOL-26. I’VE GOT FRIENDS NOW: PAEDIATRIC PATIENTS’ EXPERIENCES OF METHYLPHENIDATE TREATMENT FOR NEUROCOGNITIVE LATE-EFFECTS ASSOCIATED WITH BRAIN TUMOUR
por: Verity, Sarah, et al.
Publicado: (2020)

QOL-25. MICROSTRUCTURAL BRAIN CHANGES ASSOCIATED WITH NEUROCOGNITIVE AND FUNCTIONAL OUTCOMES OF INTRACRANIAL GERM CELL TUMUOR SURVIVORS – A DIFFUSIONAL KURTOSIS IMAGING STUDY
por: Tso, Wan-Yee Winnie, et al.
Publicado: (2020)

QOL-13. NEUROCOGNITIVE OUTCOMES ACCORDING TO RISK-ADAPTED TREATMENT REGIMENS FOR CHILDREN OLDER THAN 4 WITH MEDULLOBLASTOMA AND POSTERIOR FOSSA EPENDYMOMA – RESULTS OF THE HIT2000 TRIAL
por: Mynarek, Martin, et al.
Publicado: (2020)

QOL-17. BIOLOGICAL CORRELATES OF QUALITY OF SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN MEDULLOBLASTOMA; A META-ANALYSIS OF THE SIOP-UKCCSG-PNET3 AND HIT-SIOP-PNET4 TRIALS
por: Chevignard, Mathilde, et al.
Publicado: (2020)

QOL-04. Histology, treatment, and extent of pretreatment hydrocephalus are major determents of neurocognitive outcome for survivors of pediatric posterior fossa tumors - report from the German HIT-studies
por: Neumann-Holbeck, Anne, et al.
Publicado: (2022)

QOL-07. The importance of an onco-fertility program for pediatric neuro-oncology patients
por: IJgosse, Irene, et al.
Publicado: (2022)

QOL-44. ASSESSMENT OF NEUROCOGNITIVE FUNCTION AND MRI PARAMETERS IN LONG-TERM SURVIVORS WITH POSTERIOR FOSSA TUMORS: A COMPARISON BETWEEN MEDULLOBLASTOMAS TREATED BY REDUCED-DOSE CRANIOSPINAL IRRADIATION AND OTHER TUMORS
por: Kagawa, Naoki, et al.
Publicado: (2020)

QOL-06. QUALITY OF LIFE IN MEDULLOBLASTOMA SURVIVORS IN WESTERN MEXICO
por: del Campo, Regina M Navarro-Martin, et al.
Publicado: (2020)

QOL-27. SWALLOWING ASSESSMENT IN PEDIATRIC PATIENTS WITH BRAIN TUMOR
por: Machado, Natalia Oliveira, et al.
Publicado: (2020)

QOL-43. ENDOCRINE AND METABOLIC CHANGES IN CHILDREN TREATED FOR MEDULLOBLASTOMA
por: Kalinin, Alexey, et al.
Publicado: (2020)

QOL-48. INTERDISCIPLINARY SPIRITUAL CARE TRAINING IN PEDIATRIC NEURO-ONCOLOGY
por: Lion, Alex, et al.
Publicado: (2020)

QOL-58. ASSESSING FATIGUE EXPERIENCED BY PEDIATRIC PATIENTS WITH INTRACRANIAL NEOPLASMS
por: Eccles, Eamon, et al.
Publicado: (2020)

QOL-41. CARDIAC DYSFUNCTION IN MEDULLOBLASTOMA SURVIVORS TREATED WITH PHOTON IRRADIATION
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-15. NEURAL NETWORK INTEGRITY FOR FACIAL AFFECT RECOGNITION IN SURVIVORS OF MEDULLOBLASTOMA
por: Brinkman, Tara, et al.
Publicado: (2020)

QOL-05. TUMOR LOCATION IS LESS LIKELY INFLUENCE ON COGNITIVE DYSFUNCTION IN CHILDREN
por: Nakajima, Riho, et al.
Publicado: (2020)

QOL-36. USE OF CANNABINOIDS IN THE PEDIATRIC CENTRAL NERVOUS SYSTEM TUMOR POPULATION
por: Dorris, Kathleen, et al.
Publicado: (2020)

QOL-56. THE RELAPSED AND OR PROGRESSED BRAIN TUMOURS IN CHILDREN: RHC, GLASGOW EXPERIENCE
por: Sastry, Jairam, et al.
Publicado: (2020)

QOL-54. HEIGHT, WEIGHT AND CARDIOVASCULAR EFFECTS OF STIMULANTS ON CHILDREN WITH BRAIN TUMOR
por: Khan, Raja, et al.
Publicado: (2020)

QOL-01. Inflammatory biomarkers and psychological sequela in pediatric brain tumor survivors
por: Turner, Emily, et al.
Publicado: (2022)

QOL-29. Neuropsychology for you“ – tools to improve awareness of and access to neuropsychological care
por: Weiler-Wichtl, Liesa Josephine, et al.
Publicado: (2022)

QOL-12. Relaxation technique of imagery based story telling reduces manifestation of anxiety in children and adolescents undergoing brain tumor surgery
por: Goßler, Christina, et al.
Publicado: (2022)

QOL-57. SOUTHERN CALIFORNIA KAISER PERMANENTE PEDIATRIC NEURO-ONCOLOGY PROGRAM DEVELOPMENT
por: Tran, Hung
Publicado: (2020)

QOL-55. INTEGRATED MULTI-SCALE MODEL FOR PEDIATRIC BRAIN TUMOR SURVIVAL PREDICTION
por: Qiu, Yeping Lina, et al.
Publicado: (2020)

QOL-49. THE IMPACT OF OTOTOXICITY AND VISUAL IMPAIRMENT ON EDUCATION IN CHILDREN TREATED FOR CNS TUMOURS
por: Dulson, Harriet, et al.
Publicado: (2020)

QOL-03. Beyond Survival: Clinical Rehabilitation and Functional Optimization Pearls for the Neuro-Oncologist
por: Rosenberg, Nathan
Publicado: (2022)

QOL-31. USE OF PATIENT-REPORTED OUTCOMES TO IDENTIFY YOUTH AT RISK FOR IMPAIRED OVERALL HEALTH
por: Ingerski, Lisa, et al.
Publicado: (2020)

QOL-22. MACHINE-LEARNING INFERENCE MAY PREDICT QUALITY OF LIFE SUBGROUPS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Hengartner, Astrid C, et al.
Publicado: (2020)

QOL-21. DEVELOPMENT AND UTILISATION OF A NEURO-ONCOLOGY REHABILITATION TEAM: 2018–2019 UPDATE
por: Paisley, Helen, et al.
Publicado: (2020)

QOL-02. PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS
por: Cacciotti, Chantel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3h0h0r64j7fn01tvm1aaf85qo7